Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-44 (IGHV3-44) is a member of the immunoglobulin heavy chain variable region (VH) gene family in humans, classified within the subgroup III. This gene segment encodes part of the variable domain of the immunoglobulin (antibody) heavy chain, contributing to the antigen-binding diversity of the adaptive immune system. IGHV segments, including IGHV3-44, participate in V(D)J recombination during B cell development, ultimately shaping the specificity of antibodies. Though IGHV alleles (including IGHV3-44) are commonly analyzed in the molecular classification of B cell lymphomas and leukemias for clonality and mutation status—as a diagnostic marker—they do not in themselves function as cellular receptors or drug targets. The conventions for naming immunoglobulin variable genes are set by IMGT; the preferred standardized form is "Immunoglobulin heavy variable 3-44 (IGHV3-44)" rather than IGHVIII-44. The name "immunoglobulin heavy variable-44," "IGHVIII-44," or "IGHV(III)-44" is nonstandard and rarely used, and may lead to confusion. This gene segment is not a therapeutic target in the direct sense (unlike CD20 or PD-1); its relevance is limited to antibody gene rearrangement, immune diversity research, and diagnostics (e.g., for detecting B-cell malignancy clonality). No known approved drugs interact with this gene segment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-44 (IGHV3-44).